Cargando…

Insomnia and somnolence in idiopathic RBD: a prospective cohort study

Although some sleep disorders are markers of prodromal Parkinson’s disease and dementia with Lewy bodies, it is unclear whether insomnia and somnolence can predict disease. We assessed a large cohort of patients with idiopathic rapid eye movement sleep behavior disorder and age/sex matched controls,...

Descripción completa

Detalles Bibliográficos
Autores principales: Postuma, Ronald B., Gagnon, Jean-François, Pelletier, Amelie, Montplaisir, Jacques Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445588/
https://www.ncbi.nlm.nih.gov/pubmed/28649609
http://dx.doi.org/10.1038/s41531-017-0011-7
_version_ 1783238924575965184
author Postuma, Ronald B.
Gagnon, Jean-François
Pelletier, Amelie
Montplaisir, Jacques Y.
author_facet Postuma, Ronald B.
Gagnon, Jean-François
Pelletier, Amelie
Montplaisir, Jacques Y.
author_sort Postuma, Ronald B.
collection PubMed
description Although some sleep disorders are markers of prodromal Parkinson’s disease and dementia with Lewy bodies, it is unclear whether insomnia and somnolence can predict disease. We assessed a large cohort of patients with idiopathic rapid eye movement sleep behavior disorder and age/sex matched controls, comparing the Epworth sleepiness scale, the Insomnia Severity Index, the Pittsburgh Sleep Quality Index, and polysomnographic variables. In those with repeated scales, we assessed change over time. Finally, we assessed whether sleep abnormalities predicted defined neurodegenerative disease. The 151 patients (age = 65.9, 75% male) completed sleep scales and were included. Epworth scores were similar between patients and controls (7.0+/−4.6 vs. 7.2+/−4.7, p = 0.77), and did not progress with time (change = +0.46+/−2.1, p = 0.45). Epworth scores were similar between those who developed neurodegenerative disease and those remaining disease-free (6.7+/−4.4 vs. 7.1+/−4.7, p = 0.70). Pittsburgh Index scores were higher in patients than controls (7.2+/−3.8 vs. 4.9+/−3.4, p = 0.004), mainly driven by the sleep disturbance/medication components (reflecting rapid eye movement sleep behavior disorder symptoms/treatment). Baseline Pittsburgh scores did not predict conversion to neurodegeneration, although sleep duration increased over time in those converting to neurodegenerative disease (+0.88+/−1.32 h, p = 0.014). Insomnia index scores were higher in patients than controls (10.0+/−5.5 vs. 6.35+/−4.66, p < 0.001), but declined over time (−1.43+/−5.09, p = 0.029) particularly in those converting to neurodegenerative disease. Finally, on polysomnogram, those with increased tonic rapid eye movement had higher risk of developing defined neurodegenerative disease (HR = 1.88, p = 0.039). In summary, we found that somnolence and insomnia do not predict neurodegeneration in idiopathic rapid eye movement sleep behavior disorder. As neurodegeneration progresses through prodromal stages, patients may have increasing sleep drive and duration.
format Online
Article
Text
id pubmed-5445588
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54455882017-06-23 Insomnia and somnolence in idiopathic RBD: a prospective cohort study Postuma, Ronald B. Gagnon, Jean-François Pelletier, Amelie Montplaisir, Jacques Y. NPJ Parkinsons Dis Article Although some sleep disorders are markers of prodromal Parkinson’s disease and dementia with Lewy bodies, it is unclear whether insomnia and somnolence can predict disease. We assessed a large cohort of patients with idiopathic rapid eye movement sleep behavior disorder and age/sex matched controls, comparing the Epworth sleepiness scale, the Insomnia Severity Index, the Pittsburgh Sleep Quality Index, and polysomnographic variables. In those with repeated scales, we assessed change over time. Finally, we assessed whether sleep abnormalities predicted defined neurodegenerative disease. The 151 patients (age = 65.9, 75% male) completed sleep scales and were included. Epworth scores were similar between patients and controls (7.0+/−4.6 vs. 7.2+/−4.7, p = 0.77), and did not progress with time (change = +0.46+/−2.1, p = 0.45). Epworth scores were similar between those who developed neurodegenerative disease and those remaining disease-free (6.7+/−4.4 vs. 7.1+/−4.7, p = 0.70). Pittsburgh Index scores were higher in patients than controls (7.2+/−3.8 vs. 4.9+/−3.4, p = 0.004), mainly driven by the sleep disturbance/medication components (reflecting rapid eye movement sleep behavior disorder symptoms/treatment). Baseline Pittsburgh scores did not predict conversion to neurodegeneration, although sleep duration increased over time in those converting to neurodegenerative disease (+0.88+/−1.32 h, p = 0.014). Insomnia index scores were higher in patients than controls (10.0+/−5.5 vs. 6.35+/−4.66, p < 0.001), but declined over time (−1.43+/−5.09, p = 0.029) particularly in those converting to neurodegenerative disease. Finally, on polysomnogram, those with increased tonic rapid eye movement had higher risk of developing defined neurodegenerative disease (HR = 1.88, p = 0.039). In summary, we found that somnolence and insomnia do not predict neurodegeneration in idiopathic rapid eye movement sleep behavior disorder. As neurodegeneration progresses through prodromal stages, patients may have increasing sleep drive and duration. Nature Publishing Group UK 2017-03-20 /pmc/articles/PMC5445588/ /pubmed/28649609 http://dx.doi.org/10.1038/s41531-017-0011-7 Text en © The Author(s) 2017 This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Postuma, Ronald B.
Gagnon, Jean-François
Pelletier, Amelie
Montplaisir, Jacques Y.
Insomnia and somnolence in idiopathic RBD: a prospective cohort study
title Insomnia and somnolence in idiopathic RBD: a prospective cohort study
title_full Insomnia and somnolence in idiopathic RBD: a prospective cohort study
title_fullStr Insomnia and somnolence in idiopathic RBD: a prospective cohort study
title_full_unstemmed Insomnia and somnolence in idiopathic RBD: a prospective cohort study
title_short Insomnia and somnolence in idiopathic RBD: a prospective cohort study
title_sort insomnia and somnolence in idiopathic rbd: a prospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445588/
https://www.ncbi.nlm.nih.gov/pubmed/28649609
http://dx.doi.org/10.1038/s41531-017-0011-7
work_keys_str_mv AT postumaronaldb insomniaandsomnolenceinidiopathicrbdaprospectivecohortstudy
AT gagnonjeanfrancois insomniaandsomnolenceinidiopathicrbdaprospectivecohortstudy
AT pelletieramelie insomniaandsomnolenceinidiopathicrbdaprospectivecohortstudy
AT montplaisirjacquesy insomniaandsomnolenceinidiopathicrbdaprospectivecohortstudy